What is the address of DR. EVI KUYKEN GYNAECOLOGIE?

The registered office of DR. EVI KUYKEN GYNAECOLOGIE is located at Voort 79, 2440 Geel.

Is DR. EVI KUYKEN GYNAECOLOGIE still active?

Yes. According to the CBE (1 October 2026) DR. EVI KUYKEN GYNAECOLOGIE is active, legal situation “Normale toestand”, started on 31 March 2009.

Is DR. EVI KUYKEN GYNAECOLOGIE registered on Peppol?

No, DR. EVI KUYKEN GYNAECOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DR. EVI KUYKEN GYNAECOLOGIE?

The enterprise number of DR. EVI KUYKEN GYNAECOLOGIE is BE0810817555.

When was DR. EVI KUYKEN GYNAECOLOGIE founded?

DR. EVI KUYKEN GYNAECOLOGIE was founded on 31 March 2009.

Who are the directors of DR. EVI KUYKEN GYNAECOLOGIE?

According to the 2025 annual accounts, the directors of DR. EVI KUYKEN GYNAECOLOGIE are: Evi Catharina Kuyken.

Is DR. EVI KUYKEN GYNAECOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 March 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. EVI KUYKEN GYNAECOLOGIE make in 2025?

DR. EVI KUYKEN GYNAECOLOGIE posted a profit after taxes of € 158,940 in financial year 2025.

What is the revenue of DR. EVI KUYKEN GYNAECOLOGIE?

As a small company, DR. EVI KUYKEN GYNAECOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 319,644.

DR. EVI KUYKEN GYNAECOLOGIE (Private Limited) - Geel

Dossier DR. EVI KUYKEN GYNAECOLOGIE, printed on 1 October 2026 from databakkes.be/en/0810817555/dr-evi-kuyken-gynaecologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. EVI KUYKEN GYNAECOLOGIE from Geel, company number BE0810817555, closed financial year 2025 with a result of € 158,940 after tax. For that financial year DR. EVI KUYKEN GYNAECOLOGIE recorded a gross margin of € 319,644 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 168,539 to € 158,940. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 28, 2026.

What it is worth Healthy

€ 1.1 million

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 158,940

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 643,997

▲ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 252,320 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 138,096

▼ 16% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 774

▲ € 636 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 287,758 Gross margin 2022: € 287,758 First fiscal year in the series	€ 286,072 Gross margin 2023: € 286,072 ▼ 1% vs 2022 (€ 287,758) Unfavourable step	€ 312,741 Gross margin 2024: € 312,741 ▲ 9% vs 2023 (€ 286,072) Favourable step	€ 319,644 Gross margin 2025: € 319,644 ▲ 2% vs 2024 (€ 312,741) Favourable step	▲ 2%
Profit after taxes	€ 146,856 Profit after taxes 2022: € 146,856 First fiscal year in the series	€ 160,438 Profit after taxes 2023: € 160,438 ▲ 9% vs 2022 (€ 146,856) Favourable step	€ 168,539 Profit after taxes 2024: € 168,539 ▲ 5% vs 2023 (€ 160,438) Favourable step	€ 158,940 Profit after taxes 2025: € 158,940 ▼ 6% vs 2024 (€ 168,539) Unfavourable step	▼ 6%
Equity	€ 1,211,492 Equity 2022: € 1,211,492 First fiscal year in the series	€ 1,220,195 Equity 2023: € 1,220,195 ▲ 1% vs 2022 (€ 1,211,492) Favourable step	€ 1,243,161 Equity 2024: € 1,243,161 ▲ 2% vs 2023 (€ 1,220,195) Favourable step	€ 1,149,782 Equity 2025: € 1,149,782 ▼ 8% vs 2024 (€ 1,243,161) Unfavourable step	▼ 8%
Total debts	€ 72,263 Total debts 2022: € 72,263 First fiscal year in the series	€ 72,954 Total debts 2023: € 72,954 ▲ 1% vs 2022 (€ 72,263) Unfavourable step	€ 139 Total debts 2024: € 139 ▼ € 72,815 vs 2023 (€ 72,954) Favourable step	€ 100,774 Total debts 2025: € 100,774 ▲ € 100,636 vs 2024 (€ 139) Unfavourable step	▲ € 100,636
Cash	€ 562,354 Cash 2022: € 562,354 First fiscal year in the series	€ 366,091 Cash 2023: € 366,091 ▼ 35% vs 2022 (€ 562,354) Unfavourable step	€ 577,938 Cash 2024: € 577,938 ▲ 58% vs 2023 (€ 366,091) Favourable step	€ 643,997 Cash 2025: € 643,997 ▲ 11% vs 2024 (€ 577,938) Favourable step	▲ 11%
Land & buildings	€ 532,715 Land & buildings 2022: € 532,715 First fiscal year in the series	€ 486,466 Land & buildings 2023: € 486,466 ▼ 9% vs 2022 (€ 532,715) Unchanged	€ 440,217 Land & buildings 2024: € 440,217 ▼ 10% vs 2023 (€ 486,466) Unchanged	€ 391,583 Land & buildings 2025: € 391,583 ▼ 11% vs 2024 (€ 440,217) Unchanged	▼ 11%
Retained profit	€ 1,192,892 Retained profit 2022: € 1,192,892 First fiscal year in the series	€ 1,201,595 Retained profit 2023: € 1,201,595 ▲ 1% vs 2022 (€ 1,192,892) Favourable step	€ 1,224,561 Retained profit 2024: € 1,224,561 ▲ 2% vs 2023 (€ 1,201,595) Favourable step	€ 1,129,322 Retained profit 2025: € 1,129,322 ▼ 8% vs 2024 (€ 1,224,561) Unfavourable step	▼ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 145,572 Dividend 2024: € 145,572 Unchanged (€ 0) Unchanged	€ 252,320 Dividend 2025: € 252,320 ▲ 73% vs 2024 (€ 145,572) Unchanged	▲ 73%
Balance sheet total	€ 1,306,973 Balance sheet total 2022: € 1,306,973 First fiscal year in the series	€ 1,316,367 Balance sheet total 2023: € 1,316,367 ▲ 1% vs 2022 (€ 1,306,973) Unchanged	€ 1,266,518 Balance sheet total 2024: € 1,266,518 ▼ 4% vs 2023 (€ 1,316,367) Unchanged	€ 1,273,774 Balance sheet total 2025: € 1,273,774 ▲ 1% vs 2024 (€ 1,266,518) Unchanged	▲ 1%

Key figures of DR. EVI KUYKEN GYNAECOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. EVI KUYKEN GYNAECOLOGIE?

What happened at DR. EVI KUYKEN GYNAECOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 28, 2026 New annual accounts for financial year 2025: profit of € 158,940 (▼ 6% vs 2024). Source: NBB ↗
2023 Evi Catharina Kuyken became a director. NBB
Apr 1, 2009 New establishment in Geel. KBO
Mar 31, 2009 Start of the company according to the CBE. KBO

In short

From € 146,856 profit in 2022 to € 158,940 profit in 2025.

Paid € 283,887 in corporate taxes since 2022.

Best year ever: 2024, with € 168,539 profit.

Paid out € 397,892 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. EVI KUYKEN GYNAECOLOGIE? We notify you, reason included.

Follow DR. EVI KUYKEN GYNAECOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Evi Catharina Kuyken

DR. EVI KUYKEN GYNAECOLOGIE

Behind DR. EVI KUYKEN GYNAECOLOGIE is Evi Catharina Kuyken.

See the full network in the app

Directors

According to the 2025 annual accounts

Evi Catharina Kuyken

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Voort 79

2440 Geel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0810.817.555
VAT number: BE 0810.817.555
Registered office: Voort 79, 2440 Geel
Names & denominations: DR. EVI KUYKEN GYNAECOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 March 2009
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗